Why local antibiotic resistance data matters – Informing empiric prescribing through local data collation, app design and engagement in Zambia

Authors: Fwoloshi, Sombo, Chola, Uchizi, Nakazwe, Ruth, Tatila, Timothy, Mateele, Tebuho, Kabaso, Mwewa, Muzyamba, Theresa, Mutwale, Ilunga, Jones, Anja St Clair, Islam, Jasmin, Chikatula, Enock, Mweemba, Aggrey, Mbewe, Wilson, Mulenga, Lloyd, Aiken, Alexander M., Anitha Menon, J., Bailey, Sarah Lou, Knight, Gwenan M.

Source: In Journal of Infection and Public Health December 2023 16 Supplement 1:69-77

The influence of HIV infection on myocardial fibrosis diagnosed by cardiac magnetic resonance imaging in adults: a systematic review and meta-analysis of observation studies.

Authors: Mutengo, Katongo Hope, Lima, Bruno Bezerra, Mutale, Wilbroad, Mweemba, Aggrey, Kabwe, Lorrita, Banda, Clive, Kaayunga, Callistus, Mulenga, Mutale, Heimburger, Douglas, Masenga, Sepiso K., Carr, John Jeffrey, Kirabo, Annet

Source: Frontiers in Cardiovascular Medicine; 2025, p1-14, 14p

COVID-19 Severity and COVID-19–Associated Deaths Among Hospitalized Patients with HIV Infection — Zambia, March–December 2020

Authors: Chanda, Duncan, Minchella, Peter A., Kampamba, Davies, Itoh, Megumi, Hines, Jonas Z., Fwoloshi, Sombo, Boyd, Mary Adetinuke, Hamusonde, Kalongo, Chirwa, Lameck, Nikoi, Kotey, Chirwa, Robert, Siwingwa, Mpanji, Sivile, Suilanji, Zyambo, Khozya D., Mweemba, Aggrey, Mbewe, Nyuma, Mutengo, Katongo H., Malama, Kennedy, Agolory, Simon, Mulenga, Lloyd B.

Source: Morbidity and Mortality Weekly Report, 2021 Jun 01. 70(22), 807-810.

Access URL: https://www.jstor.org/stable/27050682

Prevalence of SARS-CoV-2 in six districts in Zambia in July, 2020: a cross-sectional cluster sample survey

Authors: Mulenga, Lloyd B, Hines, Jonas Z ^*, Fwoloshi, Sombo, Chirwa, Lameck, Siwingwa, Mpanji, Yingst, Samuel, Wolkon, Adam, Barradas, Danielle T, Favaloro, Jennifer, Zulu, James E, Banda, Dabwitso, Nikoi, Kotey I, Kampamba, Davies, Banda, Ngawo, Chilopa, Batista, Hanunka, Brave, Stevens, Thomas L, Jr, Shibemba, Aaron, Mwale, Consity, Sivile, Suilanji, Zyambo, Khozya D, Makupe, Alex, Kapina, Muzala, Mweemba, Aggrey, Sinyange, Nyambe, Kapata, Nathan, Zulu, Paul M, Chanda, Duncan, Mupeta, Francis, Chilufya, Chitalu, Mukonka, Victor, Agolory, Simon, Malama, Kennedy

Source: In The Lancet Global Health June 2021 9(6):e773-e781

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

Authors: Agweng, E, Awio, P, Bakeinyaga, G, Isabirye, C, Kabuga, U, Kasuswa, S, Katuramu, M, Kiweewa, F, Kyomugisha, H, Lutalo, E, Mulima, D, Musana, H, Musitwa, G, Musiime, V, Ndigendawan, M, Namata, H, Nkalubo, J, Labejja, P Ocitti, Okello, P, Olal, P, Pimundu, G, Segonga, P, Ssali, F, Tamale, Z, Tumukunde, D, Namala, W, Byaruhanga, R, Kayiwa, J, Tukamushaba, J, Abunyang, S, Eram, D, Denis, O, Lwalanda, R, Mugarura, L, Namusanje, J, Nankya, I, Ndashimye, E, Nabulime, E, Senfuma, O, Bihabwa, G, Buluma, E, Elbireer, A, Kamya, D, Katwere, M, Kiggundu, R, Komujuni, C, Laker, E, Lubwama, E, Mambule, I, Matovu, J, Nakajubi, A, Nakku, J, Nalumenya, R, Namuyimbwa, L, Semitala, F, Wandera, B, Wanyama, J, Mugerwa, H, Ninsiima, E, Ssenkindu, T, Mwebe, S, Atwine, L, William, H, Katemba, C, Acaku, M, Ssebutinde, P, Kitizo, H, Kukundakwe, J, Naluguza, M, Ssegawa, K, Namayanja, Nsibuka, F, Tuhirirwe, P, Fortunate, M, Acen, J, Achidri, J, Amone, A, Chamai, M, Ditai, J, Kemigisa, M, Kiconco, M, Matama, C, Mbanza, D, Nambaziira, F, Odoi, M Owor, Rweyora, A, Tumwebaze, G, Kalanzi, H, Katabaazi, J, Kiyingi, A, Mbidde, M, Mugenyi, M, Okong, P, Senoga, I, Abwola, M, Baliruno, D, Bwomezi, J, Kasede, A, Mudoola, M, Namisi, R, Ssennono, F, Tuhirwe, S, Amone, G, Abach, J, Aciro, I, Arach, B, Kidega, P, Omongin, J, Ocung, E, Odong, W, Philliam, A, Alima, H, Ahimbisibwe, B, Atuhaire, E, Atukunda, F, Bekusike, G, Bulegyeya, A, Kahatano, D, Kamukama, S, Kyoshabire, J, Nassali, A, Mbonye, A, Naturinda, T M, Ndukukire, Nshabohurira, A, Ntawiha, H, Rogers, A, Tibyasa, M, Kiirya, S, Atwongyeire, D, Nankya, A, Draleku, C, Nakiboneka, D, Odoch, D, Lakidi, L, Ruganda, R, Abiriga, R, Mulindwa, M, Balmoi, F, Kafuma, S, Moriku, E, Reid, A, Chidziva, E, Musoro, G, Warambwa, C, Tinago, G, Mutsai, S, Phiri, M, Mudzingwa, S, Bafana, T, Masore, V, Moyo, C, Nhema, R, Chitongo, S, Heyderman, Robert, Kabanga, Lucky, Kaunda, Symon, Kudzala, Aubrey, Lifa, Linly, Mallewa, Jane, Moore, Mike, Mtali, Chrissie, Musowa, George, Mwimaniwa, Grace, Sikwese, Rosemary, Ziwoya, Milton, Chitete, H Chimbaka B, Kamanga, S, Makwakwa, T Kayinga E, Mbiya, R, Mlenga, M, Mphande, T, Mtika, C, Mushani, G, Ndhlovu, O, Ngonga, M, Nkhana, I, Nyirenda, R, Cheruiyot, P, Kwobah, C, Ekiru, W Lokitala, Mokaya, M, Mudogo, A, Nzioka, A, Tanui, M, Wachira, S, Wools-Kaloustian, K, Alipalli, P, Chikatula, E, Kipaila, J, Kunda, I, Lakhi, S, Malama, J, Mufwambi, W, Mulenga, L, Mwaba, P, Mwamba, E, Namfukwe, M, Kerukadho, E, Ngwatu, B, Birungi, J, Boles, J, Burke, A, Castle, L, Ghuman, S, Kendall, L, Tebbs, S, Whittle, J, Wilkes, H, Young, N, Spyer, M, Kapuya, C, Kyomuhendo, F, Kyakundi, D, Mkandawire, N, Mulambo, S, Senyonjo, S, Angus, B, Arenas-Pinto, A, Palfreeman, A, Post, F, Ishola, D, Arribas, J, Colebunders, R, Floridia, M, Giuliano, M, Mallon, P, Walsh, P, De Rosa, M, Rinaldi, E, Weller, I, Gilks, C, Kangewende, A, Luyirika, E, Miiro, F, Ojoo, S, Phiri, S, Wapakabulo, A, Peto, T, Matenga, J, Cloherty, G, van Wyk, J, Norton, M, Lehrman, S, Lamba, P, Malik, K, Rooney, J, Snowden, W, Villacian, J, Hakim, James G, Thompson, Jennifer, Kityo, Cissy, Hoppe, Anne, Kambugu, Andrew, van Oosterhout, Joep J, Lugemwa, Abbas, Siika, Abraham, Mwebaze, Raymond, Mweemba, Aggrey, Abongomera, George, Thomason, Margaret J, Easterbrook, Philippa, Mugyenyi, Peter, Walker, A Sarah, Paton, Nicholas I

Source: In The Lancet Infectious Diseases January 2018 18(1):47-57

Histopathological Subtypes of Primary Nephrotic Syndrome in Paediatric Patients at the University Teaching Hospital in Lusaka, Zambia.

Authors: Mweemba, Aggrey^1,2,3 aggreymweemba@gmail.com, Mashanga, Paul^1,2,3, Banda, Justor^4,5

Source: Medical Journal of Zambia. Jul-Sep2022, Vol. 49 Issue 3, p220-228. 8p.

Subject Terms: *CHILD patients, *NEPHROTIC syndrome, *TEACHING hospitals, *UNIVERSITY hospitals, *FOCAL segmental glomerulosclerosis, *HISTOPATHOLOGY

Geographic Terms: LUSAKA (Zambia)

COVID-19 Vaccine Effectiveness Against Progression to In-Hospital Mortality in Zambia, 2021–2022

Authors: Chanda, Duncan, Hines, Jonas Z, Itoh, Megumi, Fwoloshi, Sombo, Minchella, Peter A, Zyambo, Khozya D, Sivile, Suilanji, Kampamba, Davies, Chirwa, Bob, Chanda, Raphael, Mutengo, Katongo, Kayembe, Mazinga F, Chewe, Webster, Chipimo, Peter, Mweemba, Aggrey, Agolory, Simon, Mulenga, Lloyd B

Source: Open forum infectious diseases. 9(9)

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100163735469.0x000001&indx=1&recIds=ETOCvdc_100163735469.0x000001

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

Authors: Hakim, James G, Thompson, Jennifer, Kityo, Cissy, Hoppe, Anne, Kambugu, Andrew, van Oosterhout, Joep J, Lugemwa, Abbas, Siika, Abraham, Mwebaze, Raymond, Mweemba, Aggrey, Abongomera, George, Thomason, Margaret J, Easterbrook, Philippa, Mugyenyi, Peter, Walker, A Sarah, Paton, Nicholas I

Source: Lancet infectious diseases. 18(1):47-57

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100131574830.0x000001&indx=1&recIds=ETOCvdc_100131574830.0x000001

Prevalence and associated factors for kidney dysfunction in hospitalized patients with COVID-19 pneumonia in Zambia.

Authors: Banda, Justor^1,2 katusib@yahoo.co.uk, Mweemba, Aggrey³, Chenga, Natasha¹, Siziya, Seter⁴

Source: Medical Journal of Zambia. Jan-Mar2022, Vol. 49 Issue 1, p34-41. 8p.

Subject Terms: *COVID-19, *HOSPITAL patients, *KIDNEY development, *KIDNEYS, *CHRONIC kidney failure

Geographic Terms: ZAMBIA

Chronic Hepatitis B Virus Coinfection Is Associated With Renal Impairment Among Zambian HIV-Infected Adults

Authors: Mweemba, Aggrey, Zanolini, Arianna, Mulenga, Lloyd, Emge, Drew, Chi, Benjamin H., Wandeler, Gilles, Vinikoor, Michael J.

Source: Clinical Infectious Diseases, 2014 Dec . 59(12), 1757-1760.

Access URL: https://www.jstor.org/stable/26362588

Effect of Baseline Renal Function on Tenofovir-Containing Antiretroviral Therapy Outcomes in Zambia

Authors: leDEA-Southern Africa, Mulenga, Lloyd, Musonda, Patrick, Mwango, Albert, Vinikoor, Michael J., Davies, Mary-Ann, Mweemba, Aggrey, Calmy, Alexandra, Stringer, Jeffrey S., Keiser, Olivia, Chi, Benjamin H., Wandeler, Gilles

Source: Clinical Infectious Diseases, 2014 May . 58(10), 1473-1480.

Access URL: http://dx.doi.org/10.1093/cid/ciu117

WCN24-824 AN IN-DEPTH EXAMINATION OF KIDNEY TRANSPLANT PATIENT SURVIVAL AT THE 6-MONTH MARK IN ZAMBIA: A SUB - SAHARAN PERSPECTIVE

Authors: Kajimotu, Teddy ¹, Kaunda, Kasakula ², Kapembwa, Kenneth ³, Mweemba, Aggrey ⁴

Source: In Kidney International Reports April 2024 9(4) Supplement:S450-S450

Prognostic model for nephrotoxicity among HIV-positive Zambian adults receiving tenofovir disoproxil fumarate-based antiretroviral therapy.

Authors: Chabala, Freeman W., Siew, Edward D., Mutale, Wilbroad, Mulenga, Lloyd, Mweemba, Aggrey, Goma, Fastone, Banda, Njeleka, Kaonga, Patrick, Wester, William C., Heimburger, Douglas C., Aliyu, Muktar H., Munkombwe, Derick

Source: PLoS ONE; 7/12/2021, Vol. 16 Issue 7, p1-15, 15p

Subject Terms: ADULTS, PROGNOSTIC models, ANTIRETROVIRAL agents, NEPHROTOXICOLOGY, HIV-positive children, CREATININE, CHRONIC kidney failure

Geographic Terms: LUSAKA (Zambia)

Evolution of HIV-1 Drug Resistance after Virological Failure of First-line Antiretroviral Therapy in Lusaka, Zambia

Authors: Hudson, F Parker, Mulenga, Lloyd, Westfall, Andrew O, Warrier, Ranjit, Mweemba, Aggrey, Saag, Michael S, Stringer, Jeffrey SA, Eron, Joseph J, Chi, Benjamin H

Source: Antiviral Therapy; May 2019, Vol. 24 Issue: 4 p291-300, 10p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Effect of Baseline Renal Function on Tenofovir-Containing Antiretroviral Therapy Outcomes in Zambia.

Authors: Mulenga, Lloyd, Musonda, Patrick, Mwango, Albert, Vinikoor, Michael J., Davies, Mary-Ann, Mweemba, Aggrey, Calmy, Alexandra, Stringer, Jeffrey S., Keiser, Olivia, Chi, Benjamin H., Wandeler, Gilles

Source: Clinical Infectious Diseases; May2014, Vol. 58 Issue 10, p1473-1480, 8p

Subject Terms: TENOFOVIR, ANTIRETROVIRAL agents, KIDNEY failure, HIV infections, EPIDERMAL growth factor receptors, THERAPEUTICS

Geographic Terms: LUSAKA (Zambia)

Prevalence and determinants of low bone mineral density among people living with HIV on antiretroviral therapy in Lusaka, Zambia: A cross-sectional study.

Authors: Webster SHAWA, Chisomo Joshua¹ chisomoshawa@gmail.com, SITALI, Jonathan Ikachana², BANDA, Justor¹, MWEEMBA, Aggrey¹

Source: East & Central African Journal of Surgery. 2024, Vol. 29 Issue 1, p4-13. 10p.

Subject Terms: *BONE density, *DUAL-energy X-ray absorptiometry, *HIV-positive persons, *HIV, *BODY mass index

This result is not displayed to guests.
Login for full access.